South Florida Research Phase I-IV

The trials here

What the 6 trials at this site are about, from their registry records.

Conditions

• Alzheimer disease3 trials
• Autism1 trial
• Bipolar disorder1 trial
• Osteoarthritis1 trial
• Schizophrenia1 trial

Phase

• Phase 23 trials
• Phase 33 trials

Status

• Recruiting5 trials
• Active, not recruiting1 trial

Lead sponsor

• Intra-Cellular Therapies, Inc.3 trials
• Bristol-Myers Squibb1 trial
• Eli Lilly and Company1 trial
• Enlivex Therapeutics Ltd.1 trial

Running trials

• Recruiting

  Intra-Articular Allocetra in Patients With Primary Knee Osteoarthritis

  NCT07580716· Phase 2· Enlivex Therapeutics Ltd.· Source

  Contact: Eduardo Viera, MD

• Recruiting

  A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder

  NCT06951698· Phase 3· Bristol-Myers Squibb· Source

  Contact: Silvia Silva Duluc, Site 0069

• Recruiting

  Multicenter Study of Lumateperone for the Treatment of Irritability Associated With Autism Spectrum Disorder in Pediatric Patients

  NCT06690398· Phase 3· Intra-Cellular Therapies, Inc.· Source

• Recruiting

  A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Agitation Associated With Alzheimer's Dementia

  NCT06651567· Phase 2· Intra-Cellular Therapies, Inc.· Source

• Recruiting

  A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's Disease

  NCT06540833· Phase 2· Intra-Cellular Therapies, Inc.· Source

• Active, not recruiting

  A Donanemab (LY3002813) Study in Participants With Preclinical Alzheimer's Disease (TRAILBLAZER-ALZ 3)

  NCT05026866· Phase 3· Eli Lilly and Company· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Alzheimer disease2 recruiting
• Autism1 recruiting
• Bipolar disorder1 recruiting
• Osteoarthritis1 recruiting
• Schizophrenia1 recruiting